New drug tested to tame arthritis flares
NCT ID NCT01143337
Summary
This study tested whether adding an experimental drug called MP-435 to a standard medication (methotrexate) could better control rheumatoid arthritis symptoms. It involved 112 adults whose arthritis was not fully controlled by methotrexate alone. For 12 weeks, participants received either MP-435 or a placebo (dummy pill) in addition to their regular methotrexate to compare safety and effectiveness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Osaka, Japan
Conditions
Explore the condition pages connected to this study.